Chapterb01
ThebNursingbProcessbandbDrugbTherapy
MULTIPLEbCHOICE
1. Thebnursebisbwritingbabnursingbdiagnosisbforbabplanbofbcarebforbabpatientbwhobhasbbeenbnewlybd
iagnosedbwithbtypeb2bdiabetes.bWhichbstatementbreflectsbthebcorrectbformatbforbabnursingbdiag
nosis?
A. Anxiety
B. Anxietybrelatedbtobnewbdrugbtherapy
C. Anxietybrelatedbtobfeelingsbaboutbdrugbtherapybasbevidencedbbybstatementsbsuchbas
―I’mbupsetbaboutbhavingbtobgivebmyselfbshots‖
D. Anxietybrelatedbtobnewbdrugbtherapybasbevidencedbbybstatementsbsuchbasb―I’mbupsetb
aboutbhavingbtobgivebmyselfbshots‖
ANS: D
2. Abpatientbisbtobreceiveboralbdigoxinb(Lanoxin)bdaily;bhowever,bbecausebhebisbunablebtobswallow,b
hebcannotbtakebitborally,basbordered.bWhatbtypebofbproblembdoesbthisbrepresent?
A. ―Rightbtime‖bproblem
B. ―Rightbdose‖bproblem
C. ―Rightbroute‖bproblem
D. ―Rightbmedication‖bproblem
ANS: C
3. Thebnursebhasbbeenbmonitoringbabpatient’sbprogressbonbabnewbdrugbregimenbsincebthebfirstbdo
sebandbdocumentingbsignsbofbpossiblebadversebeffects.bThisbexamplebillustratesbwhichbphaseb
ofbthebnursingbprocess?
A. Planning
B. Evaluation
C. Implementation
D. Nursingbdiagnosis
ANS: B
4. Thebnursebisbassignedbtobabpatientbwhobisbnewlybdiagnosedbwithbtypeb1bdiabetesbmellitus.bWhi
chbstatementbbestbillustratesbanboutcomebcriterionbforbthisbpatient?
A. Thebpatientbwillbfollowbinstructions.
B. Thebpatientbwillbnotbexperiencebcomplications.
C. Thebpatientbwillbadherebtobthebnewbinsulinbtreatmentbregimen.
D. Thebpatientbwillbdemonstratebsafebinsulinbself-administrationbtechnique.
ANS: D
5. Whichbactivitybbestbreflectsbthebimplementationbphasebofbthebnursingbprocessbforbabpatientbwhobi
sbnewlybdiagnosedbwithbtypeb1bdiabetesbmellitus?
A. Providingbeducationbregardingbself-injectionbtechnique
B. Settingbgoalsbandboutcomebcriteriabwithbthebpatient’sbinput
C. Recordingbabdrugbhistorybregardingbover-the-counterbmedicationsbusedbatbhome
D. Formulatingb nursingb diagnosesb regardingb knowledgeb deficitb relatedb tob newbtre
atmentbregimen
ANS: A
, 3
6. Thebmedicationborderbreads,b―Givebondansetronb24bmg,b30bminutesbbeforebbeginningbchemot
herapybtobpreventbnausea.‖bThebnursebnotesbthatbthebroutebisbmissingbfrombtheborder.bWhatbisbt
hebnurse’sbbestbaction?
A. Givingbthebmedicationbintravenouslybbecausebitbisbforbnauseabprevention
B. Givingbthebmedicationborallybbecausebthebtabletsbarebavailablebinb24bmgbdoses
C. Contactingbthebprescriberbtobclarifybthebroutebofbthebmedicationbordered
D. Holdingbthebmedicationbuntilbthebprescriberbreturnsbtobclarifybtheborder
ANS: C
7. Whenb theb nurseb considersb theb timingb ofb ab drugb dose,b whichb ofb theb factorsb listedb belowb isb
appropriatebtobconsiderbwhenbdecidingbwhenbtobgivebabdrug?
A. Thebpatient’sbabilitybtobswallow
B. Thebpatient’sbweight
C. Thebpatient’sblastbmeal
D. Thebpatient’sballergies
ANS: C
MULTIPLEbRESPONSE
1.bWhenbgivingbmedications,bthebnursebwillbfollowbthebrightsbofbmedicationbadministration,bwhichbin
cludebwhatbrights?bSelectballbthatbapply.
A. Rightbdrug
B. Rightbroute
C. Rightbdose
D. Rightbtime
E. Rightbpatient
F. Rightbdocumentation
ANS: A,bB,bC,bD,bE,bF
OTHER
1.b Placebthebphasesbofbthebnursingbprocessbinbthebcorrectborder,bwithb1basbthebfirstbphasebandb5ba
sbtheblastbphase.
1. Evaluation
2. NursingbDiagnoses
3. Assessment
4. Implementation
5. Planning
ANS: 3,b2,b5,b4,b1
, 4
Chapterb02bPharmacologi
cbPrinciples
MULTIPLEbCHOICE
1. Abpatientbisbreceivingbtwobdifferentbdrugs.bAtbcurrentbdosagesbandbdosagebforms,bbothbdrugsba
rebabsorbedbintobthebcirculationbinbidenticalbamounts.bThus,bbecausebtheybhavebthebsamebabs
orptionbrates,btheybare
A. inbabsteadybstate.
B. synergistic.
C. compatible.
D. bioequivalent.
ANS: D
2. Whenbgivenbanbintravenousb(IV)bmedication,bthebpatientbsaysbtobthebnurse,b―Ibusuallybtakebpills.b
Whybdoesbthisbmedicationbhavebtobbebgivenbinbthebarm?‖bWhatbisbthebnurse’sbbestbanswer?
A. ―Thebmedicationbwillbcausebfewerbadversebeffectsbwhenbgivenbintravenously.‖
B. ―ThebIVbmedicationbwillbbebabsorbedbslowlybintobthebtissuesboverbtime.‖
C. ―Thebactionbofbthebmedicationbwillbbeginbsoonerbwhenbgivenbintravenously.‖
D. ―TherebisbablowerbchancebofballergicbreactionsbwhenbdrugsbarebgivenbIV.‖
ANS: C
3. Thebnursebisbadministeringbparenteralbdrugs.bWhichbstatementbisbtruebregardingbparenteralbdr
ugs?
A. Parenteralbdrugsbbypassbthebfirst-passbeffect.
B. Absorptionbofbparenteralbdrugsbisbaffectedbbybreducedbbloodbflowbtobthebstomach.
C. Absorptionbofbparenteralbdrugsbisbalteredbbybthebpresencebofbfoodbinbthebstomach.
D. Parenteralbdrugsbexertbtheirbeffectsbwhilebcirculatingbinbthebbloodstream.
ANS: A
4. Whenbmonitoringbabpatientbonbanbinsulinbdripbtobreducebbloodbglucoseblevels,bthebnursebnotesbt
hatbthebpatient’sbglucoseblevelbisbextremelyblow,bandbthebpatientbisblethargicbandbdifficultbtobaw
aken.bThisbwouldbbebclassifiedbasbwhichbtypebofbadversebdrugbreaction?
A. Anbadversebeffect
B. Anballergicbreaction
C. Anbidiosyncraticbreaction
D. Abpharmacologicbreaction
ANS: D
5. Whenb reviewingb pharmacologyb termsb forb ab groupb ofb newlyb graduatedb nurses,b theb nurse
explainsbthatbabdrug’sbhalf-lifebisbthebtimebitbtakesbfor
A. thebdrugbtobelicitbhalfbofbitsbtherapeuticbresponse.
B. onebhalfbofbtheboriginalbamountbofbabdrugbtobreachbthebtargetbcells.
C. onebhalfbofbtheboriginalbamountbofbabdrugbtobbebremovedbfrombthebbody.
D. onebhalfbofbtheboriginalbamountbofbabdrugbtobbebabsorbedbintobthebcirculation.
ANS: C